Sarepta Therapeutics, Inc. (BMV:SRPT)
Mexico flag Mexico · Delayed Price · Currency is MXN
361.00
0.00 (0.00%)
At close: Mar 6, 2026

Sarepta Therapeutics Ratios and Metrics

Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
32,85440,598242,010152,503221,879160,750
Upgrade
Market Cap Growth
-84.09%-83.23%58.69%-31.27%38.03%-39.95%
Upgrade
Enterprise Value
34,62647,967246,521146,686212,745152,104
Upgrade
Last Close Price
361.00395.00----
Upgrade
PE Ratio
--49.37---
Upgrade
PS Ratio
0.831.036.117.2612.1911.17
Upgrade
PB Ratio
1.601.987.6010.5029.558.45
Upgrade
P/TBV Ratio
1.642.037.7410.8730.148.58
Upgrade
EV/Sales Ratio
0.891.216.226.9811.6910.57
Upgrade
EV/EBITDA Ratio
--46.25---
Upgrade
EV/EBIT Ratio
--54.25---
Upgrade
EV/FCF Ratio
-6.26-----
Upgrade
Debt / Equity Ratio
0.910.910.871.614.201.23
Upgrade
Debt / EBITDA Ratio
--3.70---
Upgrade
Net Debt / Equity Ratio
0.090.09-0.02-0.35-0.97-1.05
Upgrade
Net Debt / EBITDA Ratio
-0.16-0.16-0.101.330.752.41
Upgrade
Net Debt / FCF Ratio
-0.32-0.320.070.521.042.03
Upgrade
Asset Turnover
0.600.600.530.390.300.23
Upgrade
Inventory Turnover
2.842.842.103.905.214.12
Upgrade
Quick Ratio
1.331.332.743.233.635.05
Upgrade
Current Ratio
2.322.324.203.954.135.75
Upgrade
Return on Equity (ROE)
-53.47%-53.47%19.71%-86.15%-107.16%-49.57%
Upgrade
Return on Assets (ROA)
-11.24%-11.24%3.77%-5.24%-10.68%-9.04%
Upgrade
Return on Invested Capital (ROIC)
-44.29%-47.96%19.06%-93.16%--
Upgrade
Return on Capital Employed (ROCE)
-29.20%-29.20%6.70%-10.30%-21.40%-16.50%
Upgrade
Earnings Yield
-39.09%-31.64%2.02%-5.94%-6.19%-5.34%
Upgrade
FCF Yield
-16.85%-13.63%-2.95%-6.40%-3.13%-6.14%
Upgrade
Buyback Yield / Dilution
7.19%7.19%-16.75%-5.53%-7.75%-4.24%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.